Cargando…

Novel Therapies for Unmet Clinical Needs in Myelodysplastic Syndromes

SIMPLE SUMMARY: Several novel therapies are being developed to improve the management of patients with myelodysplastic syndromes. They include drugs aimed at improving hematopoiesis and differentiation of myeloid precursors, hypomethylating agents, several compounds that target intracellular molecul...

Descripción completa

Detalles Bibliográficos
Autores principales:	Cassanello, Giulio, Pasquale, Raffaella, Barcellini, Wilma, Fattizzo, Bruno
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	MDPI 2022
Materias:	Review
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9562187/ https://www.ncbi.nlm.nih.gov/pubmed/36230864 http://dx.doi.org/10.3390/cancers14194941

Ejemplares similares

Hypoplastic Myelodysplastic Syndromes: Just an Overlap Syndrome?
por: Fattizzo, Bruno, et al.
Publicado: (2021)

Mesenchymal Stem Cells in Aplastic Anemia and Myelodysplastic Syndromes: The “Seed and Soil” Crosstalk
por: Fattizzo, Bruno, et al.
Publicado: (2020)

Low-Risk Myelodysplastic Syndrome Revisited: Morphological, Autoimmune, and Molecular Features as Predictors of Outcome in a Single Center Experience
por: Fattizzo, Bruno, et al.
Publicado: (2022)

Bortezomib in autoimmune hemolytic anemia and beyond
por: Pasquale, Raffaella, et al.
Publicado: (2021)

Current challenges and unmet medical needs in myelodysplastic syndromes
por: Platzbecker, Uwe, et al.
Publicado: (2021)

Large Granular Lymphocyte Expansion in Myeloid Diseases and Bone Marrow Failure Syndromes: Whoever Seeks Finds
por: Fattizzo, Bruno, et al.
Publicado: (2021)

Vaccinations in hematological patients in the era of target therapies: Lesson learnt from SARS-CoV-2
por: Fattizzo, Bruno, et al.
Publicado: (2023)

New Insights in Autoimmune Hemolytic Anemia: From Pathogenesis to Therapy
por: Barcellini, Wilma, et al.
Publicado: (2020)

Complement Mediated Hemolytic Anemias in the COVID-19 Era: Case Series and Review of the Literature
por: Fattizzo, Bruno, et al.
Publicado: (2021)

Danazol Treatment for Thrombocytopenia in Myelodysplastic Syndromes: Can an “Old-fashioned” Drug be Effective?
por: Riva, Marta, et al.
Publicado: (2023)

Hematological and Extra-Hematological Autoimmune Complications after Checkpoint Inhibitors
por: Fattizzo, Bruno, et al.
Publicado: (2022)

Management of refractory autoimmune hemolytic anemia after allogeneic hematopoietic stem cell transplantation: current perspectives
por: Barcellini, Wilma, et al.
Publicado: (2019)

Confounding factors in the diagnosis and clinical course of rare congenital hemolytic anemias
por: Fattizzo, Bruno, et al.
Publicado: (2021)

Autoimmune Complications in Hematologic Neoplasms
por: Barcellini, Wilma, et al.
Publicado: (2021)

Diagnosis and Management of Autoimmune Hemolytic Anemias
por: Barcellini, Wilma, et al.
Publicado: (2022)

The Changing Landscape of Autoimmune Hemolytic Anemia
por: Barcellini, Wilma, et al.
Publicado: (2020)

Autoimmune Cytopenias in Chronic Lymphocytic Leukemia: Focus on Molecular Aspects
por: Fattizzo, Bruno, et al.
Publicado: (2020)

Immune Phenomena in Myeloid Neoplasms: An “Egg or Chicken” Question
por: Barcellini, Wilma, et al.
Publicado: (2021)

Clinical outcome of myelodysplastic syndrome progressing on hypomethylating agents with evolving frontline therapies: continued challenges and unmet needs
por: Ghorab, Ahmad, et al.
Publicado: (2022)

Clinical and prognostic significance of small paroxysmal nocturnal hemoglobinuria clones in myelodysplastic syndrome and aplastic anemia
por: Fattizzo, Bruno, et al.
Publicado: (2021)

Managing Fatigue in Patients with Paroxysmal Nocturnal Hemoglobinuria: A Patient-Focused Perspective
por: Fattizzo, Bruno, et al.
Publicado: (2022)

Difficult Cases of Autoimmune Hemolytic Anemia: A Challenge for the Internal Medicine Specialist
por: Fattizzo, Bruno, et al.
Publicado: (2020)

Difficult Cases of Paroxysmal Nocturnal Hemoglobinuria: Diagnosis and Therapeutic Novelties
por: Fattizzo, Bruno, et al.
Publicado: (2021)

Infectious Complications in Autoimmune Hemolytic Anemia
por: Giannotta, Juri Alessandro, et al.
Publicado: (2021)

Pulmonary embolism in a patient with eltrombopag-treated aplastic anaemia and paroxysmal nocturnal haemoglobinuria clone during COVID-19 pneumonia
por: Alessandro, Bosi, et al.
Publicado: (2022)

The choice of new treatments in autoimmune hemolytic anemia: how to pick from the basket?
por: Berentsen, Sigbjørn, et al.
Publicado: (2023)

Novel Therapies to Address Unmet Needs in ITP
por: Mingot-Castellano, María Eva, et al.
Publicado: (2022)

Atopic Dermatitis: Clinical Aspects and Unmet Needs
por: Lobefaro, Fabio, et al.
Publicado: (2022)

Are Patients With Autoimmune Cytopenias at Higher Risk of COVID-19 Pneumonia? The Experience of a Reference Center in Northern Italy and Review of the Literature
por: Barcellini, Wilma, et al.
Publicado: (2021)

Paroxysmal Nocturnal Hemoglobinuria in the Context of a Myeloproliferative Neoplasm: A Case Report and Review of the Literature
por: Giannotta, Juri Alessandro, et al.
Publicado: (2021)

P1482: RECOMBINANT ERYTHROPOIETIN IN AUTOIMMUNE HEMOLYTIC ANEMIA WITH INADEQUATE RETICULOCYTOSIS: A SINGLE CENTER PROSPECTIVE STUDY
por: Luca Pedone, Giacinto, et al.
Publicado: (2023)

PB1935: MANAGEMENT OF NON-SEVERE APLASTIC ANEMIA: LABORATORY WORKUP AND TREATMENT PATTERNS.
por: Cassanello, G., et al.
Publicado: (2022)

PB1990: GLYCOLYTIC ACTIVITY AND EFFECT OF EX-VIVO TREATMENT WITH THE PYRUVATE KINASE (PK) ACTIVATOR AG-946 IN RED BLOOD CELLS FROM LOW-RISK MYELODYSPLASTIC SYNDROMES PATIENTS: A PROOF-OF-CONCEPT STUDY
por: Fattizzo, Bruno, et al.
Publicado: (2023)

Pyruvate Kinase Deficiency: Current Challenges and Future Prospects
por: Fattizzo, Bruno, et al.
Publicado: (2022)

Secondary Hemophagocytic Lymphohistiocytosis and Autoimmune Cytopenias: Case Description and Review of the Literature
por: Fattizzo, Bruno, et al.
Publicado: (2021)

Clinical Applications of Hemolytic Markers in the Differential Diagnosis and Management of Hemolytic Anemia
por: Barcellini, W., et al.
Publicado: (2015)

Small Paroxysmal Nocturnal Hemoglobinuria Clones in Autoimmune Hemolytic Anemia: Clinical Implications and Different Cytokine Patterns in Positive and Negative Patients
por: Fattizzo, Bruno, et al.
Publicado: (2020)

Unmet clinical needs and burden in Angelman syndrome: a review of the literature
por: Wheeler, Anne C., et al.
Publicado: (2017)

Deciphering treatment patterns in non-severe/moderate aplastic anemia: an international observational study
por: Fattizzo, Bruno, et al.
Publicado: (2023)

Atherogenic Dyslipidemias: Unmet Needs and the Therapeutic Potential of Emerging and Novel Approaches and Drugs
por: Romandini, Alessandra, et al.
Publicado: (2023)

Cannot write session to /tmp/vufind_sessions/sess_s7tlvhb45t170omsockhti0q5p